Every effort must be deployed to limit continued spread of the etiologic agent of the COVID-19 pandemic. Mounting evidence shows that SARS-CoV-2 is amplified in the gastrointestinal tracts of infected people, excreted in stool, and detectable in wastewater at high levels^[@b1]--[@b3]^ (Rimoldi et al., 2020; medRxiv preprint doi: <https://doi.org/10.1101/2020.05.01.20086009>). We are concerned that, in areas without safely managed sanitation, drinking and household water supplies could become contaminated with the virus. This potential risk of feco-oral transmission is highest in densely populated urban centers.

SARS-CoV-2 has largely been transmitted via respiratory droplets and fomites from infected persons to the respiratory systems of susceptible individuals.^[@b4]^ However, the virus replicates in gut enterocytes^[@b1]^ and is detected in stool from patients with severe or mild COVID-19, as well as from presymptomatic and asymptomatic individuals.^[@b2],[@b3]^ Recovered COVID-19 patients may continue to shed virus for as long as 42 days after symptoms have ceased, even after they test negative by conventional respiratory tests.^[@b3],[@b5],[@b6]^

Considerable concern has been expressed in the literature that the feco-oral transmission potential for SARS-CoV-2 places endoscopists, caregivers of diapered children who shed the virus,^[@b7]^ and fecal transplant recipients^[@b8]^ at high risk of contracting the infection. For intestinal SARS-CoV-2 to transmit via fecal matter, it would have to be viable when shed and persist in the environment until a count greater than an oral infective dose is ingested by a susceptible individual. The cycle could potentially be shortcut by direct dissemination of fecal matter inadvertently from person-to-person or by pests like flies and cockroaches, or it could be broken if wastewater or domestic water treatment inactivates SARS-CoV-2. Because wastewater treatment eradicates SARS-CoV-2 and most of the worst affected countries have robust water purification systems, community feco-oral transmission has been less extensively discussed.

Feco-orally transmitted pathogens are endemic in Nigeria, which is among the top five countries worldwide contributing to diarrhea-derived under-five mortality.^[@b9]^ A principal reason why the burden from feco-oral pathogens is so high is that for most Nigerians, sewage systems are nonfunctional, incompletely functional, or nonexistent. Of six major northern Nigeria cities conducting polio virus environmental surveillance, only Abuja operates a sewage plant.^[@b10]^ In Lagos, there are multiple sewage treatment plants, but their performance is suboptimal, and they therefore pose a risk of enteric pathogen transmission to surrounding areas.^[@b11],[@b12]^ Sewage handling capacity has not grown in tandem with the explosive and continued growth of this megacity so that coverage does not extend to all residents. This situation prevails in many African urban centers and in some south Asian settings: between 60% and 95% of African city dwellers are not connected to sewerage and instead use a range of autonomous solutions or resort to open defecation.^[@b13]^ As a result, fecal matter can be deposited into the open environment, pour from toilets unconnected to sewerage into surface water, or be buried underground in soakaways and pits from where, if these receptacles are not adequately protected, it can seep into shallow wells used for irrigation, drinking, and household purposes.^[@b10],[@b13]--[@b15]^

According to the WHO/UNICEF, 663 million people in Africa and Asia do not have access to safe water, and diarrheal disease is a major cause of illness and death in those populations.^[@b16]^ In recent years, surveillance of household water at a number of African and Asian locations has revealed frequently found indicators of recent fecal contamination, such as *Escherichia coli*, or outright pathogens, including enteric viruses. In each case, links have been made to human or animal open defecation, proximal latrines, or improperly processed wastewater.^[@b17]--[@b19]^ In those settings, even pathogens known not to persist or thrive in the environment are among those recovered from contaminated household water or causing outbreaks.^[@b20],[@b21]^ Although there are as yet no reports of transmission of SARS-CoV-2 via sewage or fecal matter in settings without safely managed sanitation, or recovery from household water, these examples demonstrate that feco-oral transmission by endemic pathogenic organisms is commonplace in these settings.

There is now convincing evidence, from countries with adequate sanitation, that SARS-CoV-2 is present in feces, around toilets, and in wastewater.^[@b2],[@b22],[@b23]^ Both SARS-CoV and SARS-CoV-2 nucleic acid have been detected in wastewater during outbreaks.^[@b22],[@b24],[@b25]^ Replicable virus is less commonly reported, although it is less commonly sought, and has been found. In laboratory studies, Wang et al.^[@b25]^ found that SARS-CoV, the agent of the 2003 SARS epidemic, remains viable in water for 14 days at 4°C but for only 2 days at 20°C, suggesting that survival in tropical regions may be inadequate to sustain viability in stored water. However, coronaviruses are protected by organic matter,^[@b26]^ and this will greatly affect their survival under real-world conditions. SARS-CoV-2 RNA has been detected in substantial concentrations in wastewater and downstream water bodies.^[@b27]^ Rimoldi et al. reported that SARS-CoV-2 is susceptible to wastewater treatment and that viral infectiveness in wastewater is negligible; viral RNA was amplified in untreated but not treated wastewater.^[@b28]^ Zhang and coworkers^[@b29]^ in another preprint, however, found the China CDC-recommended sodium hypochlorite treatment of wastewater to be ineffective for the removal of SARS-CoV-2 RNA. These studies await peer review, and further investigation is needed to clarify risks.

As noted by Lodder and de Roda Husman,^[@b22]^ early finding of a COVID-19 case in the United States with no known exposure to an infected case suggests that a form other than human-to-human respiratory transmission of COVID-19 may be possible. Additional evidence comes from a recently published systematic review from Wuhan, which spotlighted a small number of patients with diarrhea but no respiratory symptoms.^[@b30]^ However, most patients in this pandemic who could have had the opportunity to be infected feco-orally to date have also been exposed to respiratory droplets or fomites; thus, the magnitude of the risk is challenging to gauge. Feco-oral transmission nonetheless remains a valid, if untested, hypothesis.^[@b1],[@b2],[@b22],[@b26],[@b30]--[@b33]^ Our review of the evidence suggests that the risk of this mode of transmission in communities without basic sanitation may be high. Unfortunately, countries without effective sanitation and water purification are also those least likely to have the wherewithal to detect live virus in environmental samples (detection of viral nucleic acid does not infer infectivity) and therefore measure this risk.^[@b10],[@b34]^

As at the time of writing, most African and Asian cities without basic or safely managed sanitation had reported relatively few COVID-19 cases. However, case numbers are increasing, and, as they rise, the viral load in untreated fecal waste pools could escalate. This is particularly true of urban settings experiencing rapid rises in case numbers such as Lagos and Kano, two Nigerian megacities. As at May 23, 2020, the Nigerian Centre for Disease Control had confirmed 3,357 and 883 cases in these states, respectively, together representing 56.3% of the number of cases nationally. Because of occupancy pressures on isolation facilities, most Nigerian cities have erected makeshift isolation and treatment facilities for patients who have tested positive, to supplement the few facilities that were available at the start of the pandemic. These new facilities often lie outside hospitals that manage their own wastewater. The same pressures on treatment facilities mean that SARS-CoV-2--infected persons in Nigeria are discharged as soon as two consecutive respiratory swabs test negative: symptom free but likely shedding the virus when they return to their communities. Other factors could additionally combine to alter the risk of feco-oral SARS-CoV-2 transmission. In Kathmandu, Nepal, where *Salmonella enterica* Typhi and Paratyphi have been shown to leach into the municipal water system, breaches occur more heavily during the rains.^[@b35]^ We note that African countries on the upswing of their COVID-19 epidemics are just beginning the rainy season. Rainy season sewage overflows can overwhelm even properly managed wastewater plants, leading to heightened enteric virus transmission.^[@b36]^ On the other hand, it is possible that only very high counts of SARS-CoV-2 would yield orally infectious doses. Thus, feco-oral transmission may only occur when the epidemic reaches an as yet unknown threshold. Either way, those at risk within those settings are poor urban communities and informal settlements, which have the worst sanitation options and access to health care. Individuals could become infected even if they were able to implement physical distancing recommendations, which themselves are a challenge, and need to be decisively protected from fecal SARS-CoV-2.^[@b37]^

Possible options for halting feco-oral SARS-CoV-2 transmission are disinfection of known open defecation sites, intensifying handwashing messages, encouraging boiling or chemical treatment of household water, and explicitly treating waste from isolation and treatment facilities. Safer sewage management should be instituted or reinstituted, as priority where possible. These include ensuring that standard operating procedures are followed, and there are no interruptions in sewage decontamination, as well as quality assurance to ensure that decontamination goals are met.^[@b11]^ Stalled or slowed sanitation projects should be expedited, and new ones could be explored. Individuals who have to work in or close to wastewater handling facilities, particularly those operating suboptimally, should be informed of their risk and provided with protection where feasible. In those situations, as research from the 2003 SARS outbreak demonstrated, aerosolized virus poses a risk for respiratory transmission in addition to any feco-oral risk that may exist.^[@b38],[@b39]^

On the positive side, fecal shedding of SARS-CoV-2 can be exploited for community surveillance of wastewater or human waste using similar methods that would be required for risk evaluation.^[@b22],[@b40]^ Enteric pathogen, polio, and antimicrobial resistance environmental surveillance could be leveraged, where these have been initiated,^[@b10],[@b41],[@b42]^ but sites with no access to sewerage, typically not used for surveillance, must also be included. In high-risk settings, waste and wastewater-based epidemiology could help balance sampling biases inherent in case- and contact-tracing--based human testing for COVID-19 and consequently predict prevalence.^[@b42],[@b43]^ It would also preemptively identify epidemic foci and ascertain the exact risk of community transmission via the fecal--oral route. Indeed, it could represent a dedicated strategy to protect the poor and marginalized in whom outbreaks in this pandemic have typically been detected with significant lags.^[@b44]^ Although much is focused on the current emergency, the potential risk from feco-oral SARS-CoV transmission should motivate and even initiate concrete steps toward lasting wastewater and sewage systems wherever possible. This would leave a post--COVID-19 development legacy that could impact disease transmission, extend the value of other disease control strategies,^[@b45]^ and improve the quality of life in the long term.
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